Harvard Medical School
Steven L. Chang, MD, MS, is an Associate Surgeon and Section Chief of Urologic Oncology at Brigham and Women's Hospital and Dana-Farber/Brigham and Women's Cancer Center. He also serves as Co-Director of the Kidney Cancer Center at Dana-Farber Cancer Institute and Associate Professor of Surgery at Harvard Medical School.
Dr. Chang received his medical degree from the College of Physicians and Surgeons at Columbia University. He subsequently completed a residency in urology and fellowship in urologic oncology at Stanford University Medical Center. During his fellowship training, Dr. Chang earned a Master of Science in Health Services Research from the Department of Health Research and Policy at Stanford University Medical School. He is board-certified in urology.
Dr. Chang cares for patients with urologic cancers, mainly using minimally invasive surgical approaches with laparoscopy and robotics. His research focuses on reducing the overall burden of urologic cancers on the health care system. Clinically, he is particularly interested in the management of kidney cancer and has established collaborations with medical oncologists at Dana-Farber/Brigham and Women's Cancer Center and interventional radiologists at Brigham and Women's Hospital to treat patients with kidney tumors, ranging from incidentally detected small renal masses to metastatic renal cell carcinoma.
In addition to his clinical and research expertise, Dr. Chang is an established educator and serves in a mentorship capacity as Co-Director of the Combined Harvard Urologic Oncology Fellowships. Additionally, he is a past recipient of numerous awards and recently was recognized by Castle Connolly America's Top Doctors and by Boston Magazine Top Doctors for his expertise in minimally invasive surgery for urological cancer.
Disclosure information not submitted.
Friday, April 28, 2023
10:40 AM – 11:30 AM CST